p42/44 mitogen-activated protein kinase regulated by p53 and nitric oxide in human pulmonary arterial smooth muscle cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 2 I, 2004, Pages 184-192

  Mizuno, Shiro ^a   Kadowaki, Maiko ^a   Demura, Yoshiki ^a   Ameshima, Shingo ^a   Miyamori, Isamu ^a   Ishizaki, Takeshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROTEIN P44; PROTEIN P53; RAF PROTEIN; RAS PROTEIN;

ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PULMONARY ARTERY; SMOOTH MUSCLE FIBER;

BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; PENICILLAMINE; PHOSPHORYLATION; PULMONARY ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4143129889     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0397OC     Document Type: Article

References (35)

1. Wagenvoort, C. A. 1981. Grading of pulmonary vasculor lesions. Histopathology 5:595-598.
2. Edwards, W. D., and J. E. Edwards. 1977. Clinical primary pulmonary hypertension: three pathologic types. Circulation 56:884-888.
3. Fishman, J. A., G. B. Ryan, and M. J. Karnovsky. 1975. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab. Invest. 32:339-351.
4. Schwartz, S. M., R. L. Heimark, and M. W. Majesky. 1990. Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70:1177-1209.
5. Mitani, Y., K. Maruyama, and M. Sakurai. 1997. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96:689-697.
6. Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272:10050-10057.
7. Sharma, R. V., E. Tan, S. Fang, M. V. Gurjar, and R. C. Bhalla. 1999. NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells. Am. J. Physiol. May 276:H1450-H1459.
8. Kibbe, M. R., S. Nie, D. W. Seol, I. Kovesdi, A. Lizonova, M. Makaroun, T. R. Billiar, and E. Tzeng. 2000. Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells. J. Vasc. Surg. 31:364-374.
9. Tanner, F. C., P. Meier, H. Greutert, C. Champion, E. G. Nabel, and T. F. Luscher. 2000. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101:1982-1989.
10. D'Souza, F. M., R. L. Sparks, H. Chen, P. J. Kadowitz, and J. R. Jeter, Jr. 2003. Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 284:C191-C199.
11. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
12. Agarwal, M. L., W. R. Taylor, M. V. Chernov, O. B. Chernova, and G. R. Stark. 1998. The p53 network. J. Biol. Chem. 273:1-4.
13. Ahn, N. G., J. E. Weiel, C. P. Chan, and E. G. Krebs. 1990. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J. Biol. Chem. 265:11487-11494.
14. Ramakrishnan, M., N. L. Musa, J. Li, P. T. Liu, R. G. Pestell, and M. B. Hershenson. 1998. Catalytic activation of extracellular signal-regulated kinases induces cyclin D1 expression in primary tracheal myocytes. Am. J. Respir. Cell Mol. Biol. 18:736-740.
15. Callsen, D., J. Pfeilschifter, and B. Brune. 1998. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition. J Immunol 161:4852-4855.
16. Gu, M., J. Lynch, and P. Brecher. 2000. Nitric oxide increases p21(Waf1/ Cip1) expression by a cGMP-dependent pathway that includes activation of extracellular signal-regulated kinase and p70(S6k). J. Biol. Chem. 275:11389-11396.
17. Wang, W., S. Wang, E. V. Nishanian, A. Del Pilar Cintron, R. A. Wesley, and R. L. Danner. 2001. Signaling by eNOS through a superoxide-dependent p42/44 mitogen-activated protein kinase pathway. Am. J. Physiol. Cell Physiol 281:C544-C554.
18. Bauer, P. M., G. M. Buga, and L. J. Ignarro. 2001. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide. Proc. Natl Acad. Sci. USA 98:12802-12807.
19. Lee, S. W., L. Fang, M. Igarashi, T. Ouchi, K. P. Lu, and S. A. Aaronson. 2000. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA 97:8302-8305.
20. Fang, L., G. Li, G. Liu, S. W. Lee, and S. A. Aaronson. 2001. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 20:1931-1939.
21. -/- vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 282:C625-C634.
22. Mizuno, S., Y. Demura, S. Ameshima, S. Okamura, I. Miyamori, and T. Ishizaki. 2002. Alkalosis stimulates endothelial nitric oxide synthase in cultured human pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 283:L113-L119.
23. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
24. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.
25. Sato, J., K. Nair, J. Hiddinga, N. L. Eberhardt, L. A. Fitzpatrick, Z. S. Katusic, and T. O'Brien. 2000. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc. Res. 47:697-706.
26. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature. 387:299-303.
27. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature. 387:296-299.
28. Ishida, A., T. Sasaguri, Y. Miwa, C. Kosaka, Y. Taba, and T. Abumiya. 1999. Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21(Waf1/Cip1/Sdi1) in vascular smooth muscle cells. Mol. Pharmacol. 56:938-946.
29. Iwashina, M., M. Shichiri, F. Marumo, and Y. Hirata. 1998. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98:1212-1218.
30. Komalavilas, P., P. K. Shah, H. Jo, and T. M. Lincoln. 1999. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274:34301-34309.
31. Yu, S. M., L. M. Hung, and C. C. Lin. 1997. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation. 95:1269-1277.
32. Pervin, S., R. Singh, and G. Chaudhuri. 2001. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc. Natl. Acad. Sci. USA 98:3583-3588.
33. Olson, M. F., H. F. Paterson, and C. J. Marshall. 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394:295-299.
34. Cip1. Mol. Cell Biol. 17:5598-5611.
35. Cip1. Mol. Cell Biol. 17:5588-5597.